|
3.3 Prévention - Vaccins
|
|
|
|
3.6 Prévention - Activité physique
|
|
|
|
4.2 Dép., diag. & prono. - Génome
|
|
|
|
4.7 Dép., diag. & prono. - Col de l'utérus
|
|
|
|
5. Traitements
|
|
|
The Drug Development Paradigm in Oncology: Proceedings of a Workshop (2017) [NAP]
|
|
|
|
|
|
This
workshop convened cancer researchers, patient advocates, and
representatives from industry, academia, and government to discuss
challenges with traditional approaches to drug development,
opportunities to improve the efficiency of drug development, and
strategies to enhance the information available about a cancer therapy
throughout its life cycle in order to improve its use in clinical
practice.
|
|
|
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
5.12.2 Immunothérapies - CAR-T
|
|
|
Could CAR-T treatments work in glioblastoma? [FierceBiotech]
|
|
|
|
|
|
The
Penn researchers were disappointed that their CAR-T treatment didn’t
produce meaningful tumor shrinkage in the glioblastoma patients in their
trial, although one patient did show stable disease at 18 months and
has maintained that response.
|
|
|
|
|
|
|
|
|
5.12.3 Immunothérapies-combinaisons
|
|
|
|
5.12.4 Immunothérapies - Essais
|
|
|
|
|
|
|
5.2 Pharma
|
|
|
|
|
|
5.2.1 Pharma - Partenariats
|
|
|
|
|
5.2.2 Pharma - Fusions & Acquisitions
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
5.3 Traitements - FDA, EMA, NICE...
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA)
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
Trump's FDA Commissioner on Drug Prices, Regulations, Science [Bloomberg]
|
|
|
|
|
|
What
we’re talking about is the clinical development process and how long
does it take to actually go through the clinical trial requirements that
FDA either imposes, or sort of steers toward, in order to demonstrate
safety and efficacy to satisfy the regulatory process and increasingly
satisfy companies’ commercial prerogatives too.
|
|
|
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
6.4 Médico-éco
|
|
|
NHS England takes tough stance on homeopathy [Pharmafile]
|
|
|
|
|
|
Homeopathy
is one of the most controversial subjects within the healthcare system
and NHS England has outlined its stance by proposing cutting funding to
the medicine. Beyond this, other over-the-counter (OTC) treatments, such
as cold and flu medicine, would also no longer be available on
prescription as part of NHS England’s action plan.
|
|
|
|
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|
|
6.7.2 Applis
|
|
|
|
6.9 Controverses
|
|
|